
Neuronetics Gains Breakthrough as New York Medicaid Expands Coverage for TMS Depression Therapy
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) announced Wednesday that New York State Medicaid will begin covering transcranial magnetic stimulation (TMS) for adults with major depressive disorder (MDD), a move …
Neuronetics Gains Breakthrough as New York Medicaid Expands Coverage for TMS Depression Therapy Read More